A. Jiménez‐Ruiz, M. García‐Grimshaw, J. Ruiz-Sandoval
{"title":"Cerebrovascular disease: Collaboration between neurologists and vascular surgeons in Mexico","authors":"A. Jiménez‐Ruiz, M. García‐Grimshaw, J. Ruiz-Sandoval","doi":"10.24875/rma.21000016","DOIUrl":"https://doi.org/10.24875/rma.21000016","url":null,"abstract":"","PeriodicalId":34905,"journal":{"name":"Revista Mexicana de Angiologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69049527","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Roberto Castañeda-Gaxiola, Luisa Fernández-López, Edmundo Arias-Gómez, Paola Prieto-Olivares, M. E. Marquina-Ramírez
Background: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is an endovascular procedure that consists of inflating a compliant balloon in the aorta through a femoral arterial access, with the intention of improving vital organs perfusion. Theoretical basis is similar to resuscitative thoracotomy (RT), with aortic clamping and/or open heart massage, but less invasive and with a lower morbidity. The aorta is divided into 3 zones considering the diaphragm and renal arteries, when using REBOA it is always preferred to inflate the balloon in Zone 1 regardless of the origin of the bleeding and it is only used in Zone 3 in exceptional cases. REBOA is used in various cases of hemorrhagic shock, either secondary to traumatismo or not, it is also used in cardiac arrest cases with good results, as shown in multiple studies in selected patients, nevertheless, using these studies the limitations or the scope of the procedure can not be clarified. Conclusions: The implementation REBOA should be determined based on training, experience, local resources and evacuation times.
{"title":"REBOA: método adyuvante o puente en el control de la hemorragia","authors":"Roberto Castañeda-Gaxiola, Luisa Fernández-López, Edmundo Arias-Gómez, Paola Prieto-Olivares, M. E. Marquina-Ramírez","doi":"10.24875/rma.21000022","DOIUrl":"https://doi.org/10.24875/rma.21000022","url":null,"abstract":"Background: Resuscitative endovascular balloon occlusion of the aorta (REBOA) is an endovascular procedure that consists of inflating a compliant balloon in the aorta through a femoral arterial access, with the intention of improving vital organs perfusion. Theoretical basis is similar to resuscitative thoracotomy (RT), with aortic clamping and/or open heart massage, but less invasive and with a lower morbidity. The aorta is divided into 3 zones considering the diaphragm and renal arteries, when using REBOA it is always preferred to inflate the balloon in Zone 1 regardless of the origin of the bleeding and it is only used in Zone 3 in exceptional cases. REBOA is used in various cases of hemorrhagic shock, either secondary to traumatismo or not, it is also used in cardiac arrest cases with good results, as shown in multiple studies in selected patients, nevertheless, using these studies the limitations or the scope of the procedure can not be clarified. Conclusions: The implementation REBOA should be determined based on training, experience, local resources and evacuation times.","PeriodicalId":34905,"journal":{"name":"Revista Mexicana de Angiologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69049111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ana K. Trujillo-Araujo, Alfonso Cossío-Zazueta, V. M. Camarillo-Nava, Roberto C. Serrato-Auld
Background: There are recognized complications in patients infected by COVID-19 and thrombotic processes are closely related to infection. Objective: To describe the factors associated with increased risk in thrombotic events in COVID-19. Material and methods: Case-control study to identify factors associated with thrombotic processes in patients with COVID-19. Descriptive, comparative and inferential statistics were used, as well as logistic regression. The value of p <0.05 was determined as statistically significant and the statistical program IBM SPSS V.25 was used. Results: 15 cases of acute thrombosis were as-sesed, 17.5% were arterial and 8.8% were venous, 66.7% (n = 10) were men. Therapeutic anticoagulation and surgical procedures were neccesary. There was an association as a risk factor the fact of presenting some comorbidity (p = 0.005), and prolonged aPTT (p = 0.10), as well as abnormalities in the D-dimer. Conclusions: Infected patients suffers from hypercoagulability and confers a high risk of thrombosis. Significant elevation of D-dimer may be one of the markers of inflammation. The condition of presenting COVID-19 is not a contraindication for any revascularization procedure, which encourages us to improve our diagnostic and therapeutic behavior in patients with COVID-19 infection.
{"title":"Trombosis aguda arterial y venosa en pacientes infectados con COVID-19","authors":"Ana K. Trujillo-Araujo, Alfonso Cossío-Zazueta, V. M. Camarillo-Nava, Roberto C. Serrato-Auld","doi":"10.24875/rma.21000017","DOIUrl":"https://doi.org/10.24875/rma.21000017","url":null,"abstract":"Background: There are recognized complications in patients infected by COVID-19 and thrombotic processes are closely related to infection. Objective: To describe the factors associated with increased risk in thrombotic events in COVID-19. Material and methods: Case-control study to identify factors associated with thrombotic processes in patients with COVID-19. Descriptive, comparative and inferential statistics were used, as well as logistic regression. The value of p <0.05 was determined as statistically significant and the statistical program IBM SPSS V.25 was used. Results: 15 cases of acute thrombosis were as-sesed, 17.5% were arterial and 8.8% were venous, 66.7% (n = 10) were men. Therapeutic anticoagulation and surgical procedures were neccesary. There was an association as a risk factor the fact of presenting some comorbidity (p = 0.005), and prolonged aPTT (p = 0.10), as well as abnormalities in the D-dimer. Conclusions: Infected patients suffers from hypercoagulability and confers a high risk of thrombosis. Significant elevation of D-dimer may be one of the markers of inflammation. The condition of presenting COVID-19 is not a contraindication for any revascularization procedure, which encourages us to improve our diagnostic and therapeutic behavior in patients with COVID-19 infection.","PeriodicalId":34905,"journal":{"name":"Revista Mexicana de Angiologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69049541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diego Chambergo-Michilot, Bruno Velit-Rios, Ángel Cueva-Parra
Objective: To know the prevalence of heart diseases and their comorbidities in all patients of a cardiology service from a Peruvian hospital. Material and methods: A descriptive observational study was conducted in a third level Peruvian hospital between January 2016 and December 2017. Results: We included 446 patients who entered the service . The most frequent heart diseases were heart failure (51.57%), congenital heart defects (23.99%), atrial fibrillation (17.49%) and acute myocardial infarction (14.57%). The most frequent comorbidities were arterial hypertension (7.62%), chronic kidney disease (5.38%) and diabetes mellitus (2.02%). Conclusions: This study reports heart diseases and comorbidities in a cardiology service. The results will serve for the approach of the sample of other studies, and could be useful for health administrators, since they will have evidence to prioritize resources for the most frequent diseases.
{"title":"Prevalencia de enfermedades cardiovasculares en el Hospital Nacional Dos de Mayo de Perú","authors":"Diego Chambergo-Michilot, Bruno Velit-Rios, Ángel Cueva-Parra","doi":"10.24875/rma.20000012","DOIUrl":"https://doi.org/10.24875/rma.20000012","url":null,"abstract":"Objective: To know the prevalence of heart diseases and their comorbidities in all patients of a cardiology service from a Peruvian hospital. Material and methods: A descriptive observational study was conducted in a third level Peruvian hospital between January 2016 and December 2017. Results: We included 446 patients who entered the service . The most frequent heart diseases were heart failure (51.57%), congenital heart defects (23.99%), atrial fibrillation (17.49%) and acute myocardial infarction (14.57%). The most frequent comorbidities were arterial hypertension (7.62%), chronic kidney disease (5.38%) and diabetes mellitus (2.02%). Conclusions: This study reports heart diseases and comorbidities in a cardiology service. The results will serve for the approach of the sample of other studies, and could be useful for health administrators, since they will have evidence to prioritize resources for the most frequent diseases.","PeriodicalId":34905,"journal":{"name":"Revista Mexicana de Angiologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69049207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Antonio Oropeza-Orozco, M. León, G. Rojas-Reyna, Salomón Cohen-Mussali, Jaime Valdés-Flores
Objective: To asses outcomes of different surgical treatment for TOS with symptom improvement and quality of life (QOL). Methods: This was a retrospective observational study of patients with TOS admitted and treated surgically at our center between March 2009 and May 2018. Sociodemographic data, clinical presentation and surgical approach was obtained from medical records. A long-term follow-up questionnaire was conducted to asses QOL. Results: A total of 23 medical records were analyzed, 83% were women. All patients treated surgically were symptomatic. 62.5% were treated with supraclavicular approach, 33.3% transaxillary and 4.1% with supraclavicular/infraclavicular approach. 22 patients responded the QOL questionnaire, 96% had complete symptom resolution after surgery. Conclusion: Patients reported good outcomes and symptom resolution after surgery. A comparison of the patients’ outcomes showed no appreciable differences between surgical ap-proaches.
{"title":"Síndrome de salida torácica: comparación entre abordajes para tratamiento quirúrgico. Experiencia de 10 años en el Centro Médico ABC","authors":"Antonio Oropeza-Orozco, M. León, G. Rojas-Reyna, Salomón Cohen-Mussali, Jaime Valdés-Flores","doi":"10.24875/rma.20000026","DOIUrl":"https://doi.org/10.24875/rma.20000026","url":null,"abstract":"Objective: To asses outcomes of different surgical treatment for TOS with symptom improvement and quality of life (QOL). Methods: This was a retrospective observational study of patients with TOS admitted and treated surgically at our center between March 2009 and May 2018. Sociodemographic data, clinical presentation and surgical approach was obtained from medical records. A long-term follow-up questionnaire was conducted to asses QOL. Results: A total of 23 medical records were analyzed, 83% were women. All patients treated surgically were symptomatic. 62.5% were treated with supraclavicular approach, 33.3% transaxillary and 4.1% with supraclavicular/infraclavicular approach. 22 patients responded the QOL questionnaire, 96% had complete symptom resolution after surgery. Conclusion: Patients reported good outcomes and symptom resolution after surgery. A comparison of the patients’ outcomes showed no appreciable differences between surgical ap-proaches.","PeriodicalId":34905,"journal":{"name":"Revista Mexicana de Angiologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69049219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Luis G. Morales-Galina, Luis O. Bobadilla-Rosado, Carlos A. Hinojosa
Since the beginning of the COVID-19 pandemic there has been many reports regarding venous and arterial thrombotic complications in patients infected with the SARS-CoV-2 virus, however the exact mechanisms for patients with COVID-19 to develop hypercoagulability states are still unknown. Prophylactic anticoagulation is considered a fundamental strategy to avoid the aforementioned complications. The objective of the present review is to guide the treatment of thromboembolic venous disease in hospitalized patients infected with SARS-CoV-2. The present article aims to review on specific recommendations of thromboembolic prophylaxis for the treatment of venous thrombotic disease in COVID-19 hospitalized patients. Hence, we differentiate between critically and non-critically ill patients as well as the duration of treatment and the recommended strategies when discharging these patients. There is still uncertainty regarding treatment options for the aforementioned complications, until an effective strategy is found, international recommendations are our best option to follow.
{"title":"Recomendaciones en el tratamiento de la enfermedad tromboembólica venosa en pacientes con infección por COVID-19","authors":"Luis G. Morales-Galina, Luis O. Bobadilla-Rosado, Carlos A. Hinojosa","doi":"10.24875/rma.20000030","DOIUrl":"https://doi.org/10.24875/rma.20000030","url":null,"abstract":"Since the beginning of the COVID-19 pandemic there has been many reports regarding venous and arterial thrombotic complications in patients infected with the SARS-CoV-2 virus, however the exact mechanisms for patients with COVID-19 to develop hypercoagulability states are still unknown. Prophylactic anticoagulation is considered a fundamental strategy to avoid the aforementioned complications. The objective of the present review is to guide the treatment of thromboembolic venous disease in hospitalized patients infected with SARS-CoV-2. The present article aims to review on specific recommendations of thromboembolic prophylaxis for the treatment of venous thrombotic disease in COVID-19 hospitalized patients. Hence, we differentiate between critically and non-critically ill patients as well as the duration of treatment and the recommended strategies when discharging these patients. There is still uncertainty regarding treatment options for the aforementioned complications, until an effective strategy is found, international recommendations are our best option to follow.","PeriodicalId":34905,"journal":{"name":"Revista Mexicana de Angiologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2020-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47351081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Romeo A. Carrasco-Alamilla, Carlos Flores-Ramírez, Miguel R. López-Ríos, Sonia E. Reyes-Chávez
Objective: To Compare the treatment with catheter-directed thrombolysis (CDT) of the iliac segment vs anticoagulation and its effect in the prevention of the post-thrombotic syndrome (PTS). Methods: Observational study of ambispective cohort in patients with deep vein thrombosis (DVT) of the iliac segment of the Central Hospital of the State of Chihuahua, during the period from March 2014 to June 2016. Patients were divided in two groups, one treated with anticoagulation and the other with CDT + anticoagulation to evaluate its effect on the prevention of SPT. Results: Of the 14 patients studied in each group, it was found that 5 (35.7%) had received anticoagulation plus CDT treatment for 2 years follow-up and had developed PTS classified by a
{"title":"Trombólisis dirigida por catéter para la prevención del síndrome postrombótico en trombosis venosa profunda del segmento iliocavo","authors":"Romeo A. Carrasco-Alamilla, Carlos Flores-Ramírez, Miguel R. López-Ríos, Sonia E. Reyes-Chávez","doi":"10.24875/rma.m19000004","DOIUrl":"https://doi.org/10.24875/rma.m19000004","url":null,"abstract":"Objective: To Compare the treatment with catheter-directed thrombolysis (CDT) of the iliac segment vs anticoagulation and its effect in the prevention of the post-thrombotic syndrome (PTS). Methods: Observational study of ambispective cohort in patients with deep vein thrombosis (DVT) of the iliac segment of the Central Hospital of the State of Chihuahua, during the period from March 2014 to June 2016. Patients were divided in two groups, one treated with anticoagulation and the other with CDT + anticoagulation to evaluate its effect on the prevention of SPT. Results: Of the 14 patients studied in each group, it was found that 5 (35.7%) had received anticoagulation plus CDT treatment for 2 years follow-up and had developed PTS classified by a","PeriodicalId":34905,"journal":{"name":"Revista Mexicana de Angiologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69051565","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rodrigo Garza-Herrera, C. Ramos-López, César Nuño-Escobar, F. Llamas-Macias, José T. R. Pulido-Abreu, Alejandro Celis-Jiménez, P. C. Olvera-Hernández
{"title":"Comparación entre el stent medicado Zilver PTX y la derivación con injerto sintético en el sector femoropoplíteo","authors":"Rodrigo Garza-Herrera, C. Ramos-López, César Nuño-Escobar, F. Llamas-Macias, José T. R. Pulido-Abreu, Alejandro Celis-Jiménez, P. C. Olvera-Hernández","doi":"10.24875/rma.m19000002","DOIUrl":"https://doi.org/10.24875/rma.m19000002","url":null,"abstract":"","PeriodicalId":34905,"journal":{"name":"Revista Mexicana de Angiologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48534441","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
S. Muñoz-Vega, Héctor Bizueto-Rosas, Alfonso Cossío-Zazueta, Roberto C. Serrato-Auld, Melanie Segoviano-Sandoval
{"title":"Experiencia del Hospital de Especialidades del Centro Médico Nacional La Raza en pacientes con trauma vascular atendidos inicialmente en otra unidad","authors":"S. Muñoz-Vega, Héctor Bizueto-Rosas, Alfonso Cossío-Zazueta, Roberto C. Serrato-Auld, Melanie Segoviano-Sandoval","doi":"10.24875/rma.m19000005","DOIUrl":"https://doi.org/10.24875/rma.m19000005","url":null,"abstract":"","PeriodicalId":34905,"journal":{"name":"Revista Mexicana de Angiologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48037939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Mishell E. Santander-Becerra, J. A. Torres-Martínez, Paloma González-Villegas, Salvador Moya-Jiménez, J. A. Serrano-Lozano
{"title":"Ultrasonido vascular en la planeación terapéutica endovascular en pacientes con isquemia crítica","authors":"Mishell E. Santander-Becerra, J. A. Torres-Martínez, Paloma González-Villegas, Salvador Moya-Jiménez, J. A. Serrano-Lozano","doi":"10.24875/rma.m19000003","DOIUrl":"https://doi.org/10.24875/rma.m19000003","url":null,"abstract":"","PeriodicalId":34905,"journal":{"name":"Revista Mexicana de Angiologia","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2019-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"69051937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：